The purpose of this study is to evaluate the safety and efficacy of the REG1 anticoagulation System in Acute Coronary Syndrome (ACS) patients undergoing cardiac catheterization.
Primary Outcome Bleeding Secondary Outcome Ischemia
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
640
The composite incidence of major and minor bleeding
Time frame: Through Day 30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Heart Center Research LLC
Huntsville, Alabama, United States
Mercy Heart & Vascular Institute
Sacramento, California, United States
Sutter Medical Center - Sacramento
Sacramento, California, United States
Scripps Mercy Hospital
San Diego, California, United States
Heart & Vascular Institute of Florida
Clearwater, Florida, United States
Jim Moran Heart & Vascular Research Institute
Fort Lauderdale, Florida, United States
University of Florida-Medicine Cardiology Research
Gainsville, Florida, United States
University of Florida at Jacksonville
Jacksonville, Florida, United States
Northeast Georgia Heart Center
Gainesville, Georgia, United States
St. Luke's Idaho Cardiology Associates
Boise, Idaho, United States
...and 33 more locations